ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

ClinicalTrials.gov ID: NCT02848274

Public ClinicalTrials.gov record NCT02848274. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 27, 2026, 5:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.

Study identification

NCT ID: NCT02848274
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Stanford University; Other
Enrollment: 2,000 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2016
Primary completion: Feb 28, 2027
Completion: Feb 28, 2027
Last update posted: Oct 21, 2025

2016 – 2027

United States locations

U.S. sites: 7
U.S. states: 6
U.S. cities: 7

Facility	City	State	ZIP	Site status
City of Hope	Duarte	California	91010	Recruiting
Stanford University, School of Medicine	Palo Alto	California	94305	Recruiting
University of Iowa	Iowa City	Iowa	52242	Recruiting
Hackensack University Medical Center	Hackensack	New Jersey	07601	Recruiting
University of Pittsburg	Pittsburgh	Pennsylvania	15260	Recruiting
University of Texas Southwestern	Dallas	Texas	75390	Recruiting
University of Utah Hospital	Salt Lake City	Utah	84132	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02848274, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 21, 2025 · Synced Jul 27, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02848274 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →